132 related articles for article (PubMed ID: 37634510)
1. CANT1 lncRNA Triggers Efficient Therapeutic Efficacy by Correcting Aberrant lncing Cascade in Malignant Uveal Melanoma.
Xing Y; Wen X; Ding X; Fan J; Chai P; Jia R; Ge S; Qian G; Zhang H; Fan X
Mol Ther; 2023 Sep; 31(9):2811. PubMed ID: 37634510
[No Abstract] [Full Text] [Related]
2. CANT1 lncRNA Triggers Efficient Therapeutic Efficacy by Correcting Aberrant lncing Cascade in Malignant Uveal Melanoma.
Xing Y; Wen X; Ding X; Fan J; Chai P; Jia R; Ge S; Qian G; Zhang H; Fan X
Mol Ther; 2017 May; 25(5):1209-1221. PubMed ID: 28330694
[TBL] [Abstract][Full Text] [Related]
3. ANRIL lncRNA triggers efficient therapeutic efficacy by reprogramming the aberrant INK4-hub in melanoma.
Xu S; Wang H; Pan H; Shi Y; Li T; Ge S; Jia R; Zhang H; Fan X
Cancer Lett; 2016 Oct; 381(1):41-8. PubMed ID: 27461581
[TBL] [Abstract][Full Text] [Related]
4. LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter.
Ni H; Chai P; Yu J; Xing Y; Wang S; Fan J; Ge S; Wang Y; Jia R; Fan X
Cell Death Dis; 2020 May; 11(5):306. PubMed ID: 32366932
[TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA PVT1 Silencing Prevents the Development of Uveal Melanoma by Impairing MicroRNA-17-3p-Dependent MDM2 Upregulation.
Wu S; Chen H; Han N; Zhang C; Yan H
Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4904-4914. PubMed ID: 31770435
[TBL] [Abstract][Full Text] [Related]
6. Low efficacy of 18F-FDG PET for detection of uveal malignant melanoma compared with 123I-IMP SPECT.
Kato K; Kubota T; Ikeda M; Tadokoro M; Abe S; Nakano S; Nishino M; Kobayashi H; Ishigaki T
J Nucl Med; 2006 Mar; 47(3):404-9. PubMed ID: 16513608
[TBL] [Abstract][Full Text] [Related]
7. High expression of lncRNA PVT1 independently predicts poor overall survival in patients with primary uveal melanoma.
Xu H; Gong J; Liu H
PLoS One; 2017; 12(12):e0189675. PubMed ID: 29244840
[TBL] [Abstract][Full Text] [Related]
8. Pathology and genetics of uveal melanoma.
Griewank KG; Murali R
Pathology; 2013 Jan; 45(1):18-27. PubMed ID: 23222249
[TBL] [Abstract][Full Text] [Related]
9. Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor.
Sato T; Eschelman DJ; Gonsalves CF; Terai M; Chervoneva I; McCue PA; Shields JA; Shields CL; Yamamoto A; Berd D; Mastrangelo MJ; Sullivan KL
J Clin Oncol; 2008 Nov; 26(33):5436-42. PubMed ID: 18838710
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA MALAT1 promotes uveal melanoma cell growth and invasion by silencing of miR-140.
Sun L; Sun P; Zhou QY; Gao X; Han Q
Am J Transl Res; 2016; 8(9):3939-3946. PubMed ID: 27725873
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA FTH1P3 facilitates uveal melanoma cell growth and invasion through miR-224-5p.
Zheng X; Tang H; Zhao X; Sun Y; Jiang Y; Liu Y
PLoS One; 2017; 12(11):e0184746. PubMed ID: 29095823
[TBL] [Abstract][Full Text] [Related]
12. The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival.
Dewaele S; Delhaye L; De Paepe B; de Bony EJ; De Wilde J; Vanderheyden K; Anckaert J; Yigit N; Nuytens J; Vanden Eynde E; Smet J; Verschoore M; Nemati F; Decaudin D; Rodrigues M; Zhao P; Jochemsen A; Leucci E; Vandesompele J; Van Dorpe J; Marine JC; Van Coster R; Eyckerman S; Mestdagh P
Oncogene; 2022 Jan; 41(1):15-25. PubMed ID: 34508176
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of 123I-IMP SPECT for the diagnosis of malignant uveal melanoma.
Goto H
Int J Clin Oncol; 2004 Apr; 9(2):74-8. PubMed ID: 15108037
[TBL] [Abstract][Full Text] [Related]
14. HIC1 modulates uveal melanoma progression by activating lncRNA-numb.
Cheng G; He J; Zhang L; Ge S; Zhang H; Fan X
Tumour Biol; 2016 Sep; 37(9):12779-12789. PubMed ID: 27449031
[TBL] [Abstract][Full Text] [Related]
15.
Hou C; Xiao L; Ren X; Cheng L; Guo B; Zhang M; Yan N
Front Genet; 2022; 13():1013475. PubMed ID: 36276954
[TBL] [Abstract][Full Text] [Related]
16. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679
[TBL] [Abstract][Full Text] [Related]
17. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
Clin Cancer Res; 2006 Feb; 12(4):1383-91. PubMed ID: 16489097
[TBL] [Abstract][Full Text] [Related]
18. New therapeutic agents in uveal melanoma.
Velho TR; Kapiteijn E; Jager MJ
Anticancer Res; 2012 Jul; 32(7):2591-8. PubMed ID: 22753717
[TBL] [Abstract][Full Text] [Related]
19. PAUPAR lncRNA suppresses tumourigenesis by H3K4 demethylation in uveal melanoma.
Ding X; Wang X; Lin M; Xing Y; Ge S; Jia R; Zhang H; Fan X; Li J
FEBS Lett; 2016 Jun; 590(12):1729-38. PubMed ID: 27214741
[TBL] [Abstract][Full Text] [Related]
20. Identification of Six Autophagy-Related-lncRNA Prognostic Biomarkers in Uveal Melanoma.
Chen Y; Chen L; Wang J; Tan J; Wang S
Dis Markers; 2021; 2021():2401617. PubMed ID: 34426753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
